Global Synthetic Blood Substitutes and Blood Product Market 2025–2034
Description
Synthetic Blood Substitutes and Blood Product Market Size, Trends and Insights By Source (Human Blood, Animal Blood, Synthetic Polymers, Stem Cells, Others), By Type (Perfluorocarbon Based Product (PFC), Haemoglobin Based Oxygen Carrier, Synthetic Platelet, Recombinant Factor, Blood Expander), By Installation Type (Cardiovascular Diseases, Anaemia, Organ Transplant, Injury and Trauma, Others), By End-User (Hospitals and Clinics, Blood Banks, Others), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2025–2034
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research Methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Synthetic Blood Substitutes and Blood Product Market (2025 – 2034) (USD Million)
- 2.2 Global Synthetic Blood Substitutes and Blood Product Market: snapshot
- Chapter 3. Global Synthetic Blood Substitutes and Blood Product Market – Industry Analysis
- 3.1 Synthetic Blood Substitutes and Blood Product Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Rising Awareness of the Benefits of Artificial Blood
- 3.2.2 Increasing Use of Blood Substitutes in Organ Transplantation
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porters Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Source
- 3.7.2 Market Attractiveness Analysis By Type
- 3.7.3 Market Attractiveness Analysis By Installation Type
- 3.7.4 Market Attractiveness Analysis By End-User
- Chapter 4. Global Synthetic Blood Substitutes and Blood Product Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Synthetic Blood Substitutes and Blood Product Market: Company Market Share, 2024
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- Chapter 5. Global Synthetic Blood Substitutes and Blood Product Market – Source Analysis
- 5.1 Global Synthetic Blood Substitutes and Blood Product Market Overview: By Source
- 5.1.1 Global Synthetic Blood Substitutes and Blood Product Market Share, By Source, 2024 and 2034
- 5.2 Human Blood
- 5.2.1 Global Synthetic Blood Substitutes and Blood Product Market by Human Blood, 2025 – 2034 (USD Million)
- 5.3 Animal Blood
- 5.3.1 Global Synthetic Blood Substitutes and Blood Product Market by Animal Blood, 2025 – 2034 (USD Million)
- 5.4 Synthetic Polymers
- 5.4.1 Global Synthetic Blood Substitutes and Blood Product Market by Synthetic Polymers, 2025 – 2034 (USD Million)
- 5.5 Stem Cells
- 5.5.1 Global Synthetic Blood Substitutes and Blood Product Market by Stem Cells, 2025 – 2034 (USD Million)
- 5.6 Others
- 5.6.1 Global Synthetic Blood Substitutes and Blood Product Market by Others, 2025 – 2034 (USD Million)
- Chapter 6. Global Synthetic Blood Substitutes and Blood Product Market – Type Analysis
- 6.1 Global Synthetic Blood Substitutes and Blood Product Market Overview: By Type
- 6.1.1 Global Synthetic Blood Substitutes and Blood Product Market Share, By Type, 2024 and 2034
- 6.2 Perfluorocarbon Based Product (PFC)
- 6.2.1 Global Synthetic Blood Substitutes and Blood Product Market by Perfluorocarbon Based Product (PFC), 2025 – 2034 (USD Million)
- 6.3 Haemoglobin Based Oxygen Carrier
- 6.3.1 Global Synthetic Blood Substitutes and Blood Product Market by Haemoglobin Based Oxygen Carrier, 2025 – 2034 (USD Million)
- 6.4 Synthetic Platelet
- 6.4.1 Global Synthetic Blood Substitutes and Blood Product Market by Synthetic Platelet, 2025 – 2034 (USD Million)
- 6.5 Recombinant Factor
- 6.5.1 Global Synthetic Blood Substitutes and Blood Product Market by Recombinant Factor, 2025 – 2034 (USD Million)
- 6.6 Blood Expander
- 6.6.1 Global Synthetic Blood Substitutes and Blood Product Market by Blood Expander, 2025 – 2034 (USD Million)
- Chapter 7. Global Synthetic Blood Substitutes and Blood Product Market – Installation Type Analysis
- 7.1 Global Synthetic Blood Substitutes and Blood Product Market Overview: By Installation Type
- 7.1.1 Global Synthetic Blood Substitutes and Blood Product Market Share, By Installation Type, 2024 and 2034
- 7.2 Cardiovascular Diseases
- 7.2.1 Global Synthetic Blood Substitutes and Blood Product Market by Cardiovascular Diseases, 2025 – 2034 (USD Million)
- 7.3 Anaemia
- 7.3.1 Global Synthetic Blood Substitutes and Blood Product Market by Anaemia, 2025 – 2034 (USD Million)
- 7.4 Organ Transplant
- 7.4.1 Global Synthetic Blood Substitutes and Blood Product Market by Organ Transplant, 2025 – 2034 (USD Million)
- 7.5 Injury and Trauma
- 7.5.1 Global Synthetic Blood Substitutes and Blood Product Market by Injury and Trauma, 2025 – 2034 (USD Million)
- 7.6 Others
- 7.6.1 Global Synthetic Blood Substitutes and Blood Product Market by Others, 2025 – 2034 (USD Million)
- Chapter 8. Global Synthetic Blood Substitutes and Blood Product Market – End-User Analysis
- 8.1 Global Synthetic Blood Substitutes and Blood Product Market Overview: By End-User
- 8.1.1 Global Synthetic Blood Substitutes and Blood Product Market Share, By End-User, 2024 and 2034
- 8.2 Hospitals and Clinics
- 8.2.1 Global Synthetic Blood Substitutes and Blood Product Market by Hospitals and Clinics, 2025 – 2034 (USD Million)
- 8.3 Blood Banks
- 8.3.1 Global Synthetic Blood Substitutes and Blood Product Market by Blood Banks, 2025 – 2034 (USD Million)
- 8.4 Others
- 8.4.1 Global Synthetic Blood Substitutes and Blood Product Market by Others, 2025 – 2034 (USD Million)
- Chapter 9. Synthetic Blood Substitutes and Blood Products Market Regional Analysis
- 9.1 Global Synthetic Blood Substitutes and Blood Products Market Regional Overview
- 9.2 Global Synthetic Blood Substitutes and Blood Products Market Share by Region, 2024 & 2034 (USD Million)
- 9.3. North America
- 9.3.1 North America Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
- 9.3.1.1 North America Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
- 9.4 North America Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
- 9.4.1 North America Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
- 9.5 North America Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
- 9.5.1 North America Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
- 9.6 North America Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
- 9.6.1 North America Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
- 9.7 North America Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
- 9.7.1 North America Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
- 9.8. Europe
- 9.8.1 Europe Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
- 9.8.1.1 Europe Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
- 9.9 Europe Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
- 9.9.1 Europe Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
- 9.10 Europe Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
- 9.10.1 Europe Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
- 9.11 Europe Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
- 9.11.1 Europe Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
- 9.12 Europe Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
- 9.12.1 Europe Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
- 9.13. Asia Pacific
- 9.13.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
- 9.13.1.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
- 9.14 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
- 9.14.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
- 9.15 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
- 9.15.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
- 9.16 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
- 9.16.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
- 9.17 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
- 9.17.1 Asia Pacific Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
- 9.18. Latin America
- 9.18.1 Latin America Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
- 9.18.1.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
- 9.19 Latin America Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
- 9.19.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
- 9.20 Latin America Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
- 9.20.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
- 9.21 Latin America Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
- 9.21.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
- 9.22 Latin America Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
- 9.22.1 Latin America Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
- 9.23. The Middle-East and Africa
- 9.23.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, 2025 – 2034 (USD Million)
- 9.23.1.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Country, 2025 – 2034 (USD Million)
- 9.24 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034
- 9.24.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Source, 2025 – 2034 (USD Million)
- 9.25 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034
- 9.25.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Type, 2025 – 2034 (USD Million)
- 9.26 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034
- 9.26.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by Installation Type, 2025 – 2034 (USD Million)
- 9.27 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034
- 9.27.1 The Middle-East and Africa Synthetic Blood Substitutes and Blood Products Market, by End-User, 2025 – 2034 (USD Million)
- Chapter 10. Company Profiles
- 10.1 Aurum Biosciences Ltd
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Baxter International
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Dentritech Inc
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Hemoglobin Oxygen Therapeutics LLC
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 HemoBioTech Inc.
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Hemarina SA
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 KaloCyte Inc.
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 NuvOx Pharma LLC
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 SpheriTech Ltd
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 HemCon Medical Technologies Inc.
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 Matrox Medical Inc.
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Sorrento Therapeutics Inc.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.13 Xeris Pharmaceuticals Inc.
- 10.13.1 Overview
- 10.13.2 Financials
- 10.13.3 Product Portfolio
- 10.13.4 Business Strategy
- 10.13.5 Recent Developments
- 10.14 BPL Medical Technologies
- 10.14.1 Overview
- 10.14.2 Financials
- 10.14.3 Product Portfolio
- 10.14.4 Business Strategy
- 10.14.5 Recent Developments
- 10.15 Sangart Inc.
- 10.15.1 Overview
- 10.15.2 Financials
- 10.15.3 Product Portfolio
- 10.15.4 Business Strategy
- 10.15.5 Recent Developments
- 10.16 Hemosol Inc.
- 10.16.1 Overview
- 10.16.2 Financials
- 10.16.3 Product Portfolio
- 10.16.4 Business Strategy
- 10.16.5 Recent Developments
- 10.17 Sonaca Group
- 10.17.1 Overview
- 10.17.2 Financials
- 10.17.3 Product Portfolio
- 10.17.4 Business Strategy
- 10.17.5 Recent Developments
- 10.18 The Medicines Company
- 10.18.1 Overview
- 10.18.2 Financials
- 10.18.3 Product Portfolio
- 10.18.4 Business Strategy
- 10.18.5 Recent Developments
- 10.19 Erytech Pharma
- 10.19.1 Overview
- 10.19.2 Financials
- 10.19.3 Product Portfolio
- 10.19.4 Business Strategy
- 10.19.5 Recent Developments
- 10.20 American Red Cross
- 10.20.1 Overview
- 10.20.2 Financials
- 10.20.3 Product Portfolio
- 10.20.4 Business Strategy
- 10.20.5 Recent Developments
- 10.21 Hemerus Medical B.V.
- 10.21.1 Overview
- 10.21.2 Financials
- 10.21.3 Product Portfolio
- 10.21.4 Business Strategy
- 10.21.5 Recent Developments
- 10.22 Others.
- 10.22.1 Overview
- 10.22.2 Financials
- 10.22.3 Product Portfolio
- 10.22.4 Business Strategy
- 10.22.5 Recent Developments
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.



